EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Angiogenic factors and fetal Doppler for predicting adverse pregnancy outcome in early‐onset small fetuses with and without pre‐eclampsia

E Bonacina, M Armengol-Alsina, A Casellas, M Dalmau iD, P Diaz iD, E Roldán iD, J Temprado, M Duaso, Q Ampurdanes, M San José, T Armengol, Z Lizarraga und 2 weitere

Ultrasound in Obstetrics & Gynecology · 2026

DOI: 10.1002/uog.70188 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2026. Verfasst von E Bonacina und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Pre-Eclampsia, Ultrasonography, Prenatal, Placenta Growth Factor. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To assess the predictive performance of angiogenic factors and fetal Doppler, alone and in combination, for composite adverse perinatal outcome (CAPO) in early‐onset small‐for‐gestational age (SGA) and fetal growth restriction (FGR), in cases both with and without pre‐eclampsia (PE), in order to evaluate the ability of these markers to predict adverse outcomes beyond their established association with PE and to better delineate the specific contribution of PE to their predictive value.

Methods

This was a retrospective observational study conducted at Vall d'Hebron University Hospital, Barcelona, Spain, between January 2016 and January 2022. The study population included singleton pregnancies with an estimated fetal weight < 10 th percentile, diagnosed with fetal smallness between 20 + 0 and 31 + 6 weeks' gestation, with fetal Doppler ultrasound data and available angiogenic factor measurements obtained at diagnosis. Placental growth factor (PlGF) and soluble fms‐like tyrosine kinase‐1 (sFlt‐1) were measured at initial assessment. CAPO was defined as the presence of at least one of the following: 5‐min Apgar score < 7; umbilical cord arterial pH < 7.0; admission to the neonatal intensive care unit for > 48 h; stillbirth; neonatal death; respiratory distress syndrome; bronchopulmonary dysplasia; neonatal sepsis; necrotizing enterocolitis; Grade‐III–IV retinopathy of prematurity; Grade‐III–IV intraventricular hemorrhage; or periventricular leukomalacia. Predictive performance for CAPO and subsequent PE was assessed using receiver‐operating‐characteristics (ROC)‐curve analysis and area under the ROC curve (AUC) comparisons for fetal Doppler and angiogenic factors, alone and combined, within logistic regression models. Sensitivity, false‐positive rate, positive predictive value and negative predictive value were calculated. All analyses were stratified according to PE development at any time before delivery.

Results

Overall, 469 women with an early‐onset small fetus were included. PE was present at diagnosis in 74/469 (15.8%) cases and developed later in 83 (17.7%) cases. CAPO occurred in 46.5% of cases. In the overall cohort, PlGF combined with fetal Doppler findings showed the highest predictive performance for CAPO (AUC, 0.866 (95% CI, 0.833–0.899)), outperforming fetal Doppler alone. Notably, the performance of the combined model was not significantly different from PlGF alone (AUC, 0.862 (95% CI, 0.828–0.895); P = 0.621). These findings were consistent in pregnancies without PE, in which PlGF remained the best‐performing single predictor of CAPO (AUC, 0.797 (95% CI, 0.740–0.854)). In pregnancies with PE at any time, the best‐performing single predictor was the sFlt‐1/PlGF ratio (AUC, 0.802 (95% CI, 0.728–0.876)). For the prediction of subsequent PE after enrolment, the sFlt‐1/PlGF ratio alone (AUC, 0.861 (95% CI, 0.821–0.901)) and in combination with fetal Doppler (AUC, 0.862 (95% CI, 0.822–0.902)) achieved the highest predictive performance. Combining fetal Doppler findings with angiogenic factors reduced false‐positive rates, but did not improve sensitivity.

Conclusion

This study confirmed the robust predictive performance of PlGF and the sFlt‐1/PlGF ratio for identifying CAPO and PE in early‐onset SGA/FGR. The predictive value of PlGF and fetal Doppler remained consistent irrespective of PE status, while the sFlt‐1/PlGF ratio showed reduced predictive accuracy in non‐PE pregnancies, but still outperformed Doppler. These findings support the integration of angiogenic factors into the clinical assessment of early‐onset SGA/FGR, for both cases with and those without PE. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal Growth RetardationPre-EclampsiaUltrasonography, PrenatalPlacenta Growth FactorUltrasonography, DopplerHumansFemalePregnancyRetrospective StudiesPredictive Value of TestsInfant, NewbornInfant, Small for Gestational AgeAdultPregnancy OutcomeBiomarkersVascular Endothelial Growth Factor Receptor-1Gestational AgeSpainUmbilical ArteriesROC Curve

Stichwörter der Autor:innen

DopplerPlGFSGAangiogenic factorsfetal growth restrictionsFlt‐1

Substanzen

Placenta Growth FactorBiomarkersVascular Endothelial Growth Factor Receptor-1PGF protein, humanFLT1 protein, human

Autor:innen und Institutionen

  • Department of Obstetrics, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Departament de Pediatria, Obstetrícia i Ginecologia i de Medicina Preventiva i Salut Pública, Universitat Autònoma de Barcelona, Bellaterra, Spain.

ORCID-Profile: M Dalmau, P Diaz, E Roldán, M Mendoza

Zitieren

APA

Bonacina, E., Armengol-Alsina, M., Casellas, A., Dalmau, M., Diaz, P., Roldán, E., Temprado, J., Duaso, M., Ampurdanes, Q., San José, M., Armengol, T., Lizarraga, Z., Maiz, N., & Mendoza, M. (2026). Angiogenic factors and fetal Doppler for predicting adverse pregnancy outcome in early‐onset small fetuses with and without pre‐eclampsia. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.70188

Vancouver

Bonacina E, Armengol-Alsina M, Casellas A, Dalmau M, Diaz P, Roldán E, et al. Angiogenic factors and fetal Doppler for predicting adverse pregnancy outcome in early‐onset small fetuses with and without pre‐eclampsia. Ultrasound in Obstetrics & Gynecology. 2026. doi:10.1002/uog.70188

BibTeX
@article{Bonacina2026,
  author = {Bonacina, E and Armengol-Alsina, M and Casellas, A and Dalmau, M and Diaz, P and Roldán, E and Temprado, J and Duaso, M and Ampurdanes, Q and San José, M and Armengol, T and Lizarraga, Z and Maiz, N and Mendoza, M},
  title = {Angiogenic factors and fetal Doppler for predicting adverse pregnancy outcome in early‐onset small fetuses with and without pre‐eclampsia},
  journal = {Ultrasound in Obstetrics & Gynecology},
  year = {2026},
  doi = {10.1002/uog.70188}
}
Kostenlos starten →